Hawk Ridge Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-21,200
Closed -$861K – 42
2023
Q1
$861K Hold
21,200
– – 0.05% 40
2022
Q4
$953K Buy
+21,200
New +$960K 0.06% 43

Other funds holding TNDM

Hawk Ridge Capital Management's TNDM Position: Q2 2023 in Review

Hawk Ridge Capital Management sold out of Tandem Diabetes Care (TNDM) in Q2 2023, closing a stake of 21,200 shares — an estimated $861K sold.

Hawk Ridge Capital Management first reported a position in TNDM in Q4 2022 and held it in 2 quarters. The position peaked at $953K in Q4 2022. 247 funds tracked by Wall St. Rank hold TNDM as of Q2 2023.

  • Hawk Ridge Capital Management reported no remaining Tandem Diabetes Care position as of Q2 2023 after selling out during the quarter.
  • Hawk Ridge Capital Management sold 21,200 Tandem Diabetes Care shares in Q2 2023, an estimated $861K.
  • Hawk Ridge Capital Management first reported a position in Tandem Diabetes Care in Q4 2022 and held it in 2 quarters.
  • Hawk Ridge Capital Management's Tandem Diabetes Care position peaked at $953K in Q4 2022.
  • 247 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2023.

Based on Hawk Ridge Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.